Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03826264 · ClinicalTrials.gov registry record
Transpacific TAVR Registry
A clinical trial of Heart Valve Diseases and Aortic Valve Insufficiency, sponsored by Duk-Woo Park, MD.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 7
- Study locations
NCT03826264 is a study of Heart Valve Diseases and Aortic Valve Insufficiency that is actively recruiting participants, run by Duk-Woo Park, MD. The registered enrollment target is 10,000 participants, above the 316-participant average among 13 other Heart Valve Diseases trials with a reported enrollment target (3065% higher). The trial reports 7 study locations across 3 states.
The verdict
NCT03826264, a study of Heart Valve Diseases and Aortic Valve Insufficiency, is actively recruiting participants, sponsored by Duk-Woo Park, MD.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 7
- Study locations
Study Summary
This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.
Conditions Studied
Interventions
- PROCEDURE TAVR
Study Locations (7)
Other
- Second Affiliated Hospital of Zhejiang University - Hangzhou
- Bucheon Sejong Hospital - Bucheon-si
- Chungnam National University Hospital - Daejeon
- Asan Medical Center - Seoul
- Seoul National University Hospital - Seoul
California
- Stanford University - Stanford
Illinois
- Northwestern Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2019-06-15 |
| Est. Completion | 2036-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03826264
The ClinicalTrials.gov registry entry for NCT03826264 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 316-participant average among 13 other Heart Valve Diseases trials with a reported enrollment target (3065% higher). The listed sponsor is Duk-Woo Park, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Valve Diseases appearing as the primary indexed condition, and to 1 intervention - of which TAVR is the first listed.
NCT03826264 reports 7 study locations spanning 3 distinct geographic areas - top geographies include Other, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT03826264 about?
NCT03826264 is a clinical study titled "Transpacific TAVR Registry". This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.
What is the current status of trial NCT03826264?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2019-06-15. Estimated completion is 2036-12-31.
What conditions does trial NCT03826264 study?
This clinical trial studies the following conditions: Heart Valve Diseases, Aortic Valve Insufficiency.
What interventions are being tested in trial NCT03826264?
The interventions under investigation include: TAVR (PROCEDURE).
Who is sponsoring clinical trial NCT03826264?
This trial is sponsored by Duk-Woo Park, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03826264 being conducted?
This trial has 7 study locations across California, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Valve Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
The TRICURE EFS Study
RECRUITING · NA
-
Warfarin Patient Self-management Implementation in the US Healthcare System
RECRUITING · NA
-
EFS of the DUO System for Tricuspid Regurgitation
RECRUITING · NA
-
TRISCEND II Pivotal Trial
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.